These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2327116)
61. Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction. Sharpe DN; Norris RM; McL White B Br Heart J; 1975 May; 37(5):530-3. PubMed ID: 1137662 [TBL] [Abstract][Full Text] [Related]
62. The bioavailability of digoxin. Lancet; 1972 Aug; 2(7772):311-2. PubMed ID: 4115037 [No Abstract] [Full Text] [Related]
63. Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs. Button C; Gross DR; Johnston JT; Yakatan GJ Am J Vet Res; 1980 Aug; 41(8):1230-7. PubMed ID: 7447117 [TBL] [Abstract][Full Text] [Related]
64. Bioavailability of drugs: the digoxin dilemma. Greenblatt DJ; Smith TW; Koch-Weser J Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491 [TBL] [Abstract][Full Text] [Related]
65. Fasting and postprandial absorption of digoxin from a microencapsulated formulation. Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO Eur J Clin Pharmacol; 1983; 25(2):207-10. PubMed ID: 6628502 [TBL] [Abstract][Full Text] [Related]
66. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. Shah J; Wesnes KA; Kovelesky RA; Henney HR Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304 [TBL] [Abstract][Full Text] [Related]
67. Variation in the biological availability of digoxin. Shaw TR; Howard MR; Hamer J Lancet; 1972 Aug; 2(7772):303-7. PubMed ID: 4115034 [No Abstract] [Full Text] [Related]
68. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment. Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776 [TBL] [Abstract][Full Text] [Related]
69. [Clinical study on digoxin tablets with high bioavailability (author's transl)]. Flasch CI; Heinz N Arzneimittelforschung; 1979; 29(6):961-4. PubMed ID: 582792 [TBL] [Abstract][Full Text] [Related]
70. Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. Nikolova Z; Peng B; Hubert M; Sieberling M; Keller U; Ho YY; Schran H; Capdeville R Cancer Chemother Pharmacol; 2004 May; 53(5):433-8. PubMed ID: 15132131 [TBL] [Abstract][Full Text] [Related]
71. Effects of the concomitant administration of tamsulosin (0.8 mg) on the pharmacokinetic and safety profile of intravenous digoxin (Lanoxin) in normal healthy subjects: a placebo-controlled evaluation. Miyazawa Y; Paul Starkey L; Forrest A; Schentag JJ; Kamimura H; Swarz H; Ito Y J Clin Pharm Ther; 2002 Feb; 27(1):13-9. PubMed ID: 11846858 [TBL] [Abstract][Full Text] [Related]
72. Diclofenac potassium 12.5 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative, bioavailability study versus diclofenac potassium 12.5 mg tablets. Kienzler JL; Gold M Int J Clin Pharmacol Ther; 2012 Jun; 50(6):438-44. PubMed ID: 22677305 [TBL] [Abstract][Full Text] [Related]
73. Digoxin compliance in patients from general practice. Johnston GD; McDevitt DG Br J Clin Pharmacol; 1978 Oct; 6(4):339-43. PubMed ID: 698030 [TBL] [Abstract][Full Text] [Related]
78. Comparison of medigoxin and digoxin in the control of atrial fibrillation. Coburn P; Kongola GM; Mawer GE Br J Clin Pharmacol; 1979 Jul; 8(1):53-8. PubMed ID: 552298 [TBL] [Abstract][Full Text] [Related]
79. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions. Boerner D; Olcay A; Schaumann W; Weiss W Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714 [TBL] [Abstract][Full Text] [Related]
80. Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation. Hull MW; Harris M; Lima V; Guillemi S; Harrigan PR; Montaner JS J Clin Pharmacol; 2009 Feb; 49(2):155-61. PubMed ID: 19179294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]